Brain-behavior relationship in a case of successful ECT for drug refractory catatonic OCD

Journal of ECT

Volumn 28, Issue 3, 2012, Pages 190-193

  D'Urso, Giordano ^a   Mantovani, Antonio ^b   Barbarulo, Anna Maria ^c   Labruna, Ludovica ^d   Muscettola, Giovanni ^a,e  

^a Edificio 18   (Italy)

^b Columbia University ^*  (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

brain imaging; brain lateralization; brain stimulation; mind brain relationship; neurological soft signs

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE; CLONAZEPAM; HALOPERIDOL; IMIPRAMINE; PAROXETINE; PERPHENAZINE; PIMOZIDE; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CASE REPORT; CATATONIA; COGNITIVE THERAPY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; HUMAN; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BEHAVIOR; BRAIN; CATATONIA; CEREBROVASCULAR CIRCULATION; CYSTEINE; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; ORGANOTECHNETIUM COMPOUNDS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPHYSIOLOGY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865800557     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182542649     Document Type: Article

References (20)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder. Arlington, VA: American Psychiatric Association; 2007. Available online at: http://psychiatryonline.org/ content.aspx?bookid=28§ionid=1678180. Accessed April 11, 2012.
2. Mantovani A, Lisanby SH. Brain stimulation in the treatment of anxiety disorders. In: Simpson HB, Neria Y, Lewis-Fernandez R, et al, eds. Understanding Anxiety: Clinical and Research Perspectives From the Columbia University Department of Psychiatry. Cambridge, England: Cambridge University Press; 2010.
3. Goodman WK, McDougle CJ, Barr LC, et al. Biological approaches to treatment-resistant OCD. J Clin Psychiatry. 1993;54(suppl):16-26.
4. Insel TR. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:739-744.
5. Rauch SL, Shin LM, Dougherty DD, et al. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: A PET symptom provocation study. Neuropsychopharmacology. 2002;27:782-791.
6. Kang DH, Kwon JS, Kim JJ, et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2003;107:291-297.
7. Nabeyama M, Nakagawa A, Yoshiura T, et al. Functional MRI study of brain activation alterations in patients with obsessive-compulsive disorder after symptom improvement. Psychiatry Res. 2008;163(3):236-247.
8. Ciesielski KT, Rauch SL, Ahlfors SP, et al. Role of medial cortical networks for anticipatory processing in obsessive-compulsive disorder. Hum Brain Mapp. Article published online August 31, 2011.
9. Koçak OM, Ö zpolat AY, Atbazo?lu C, et al. Cognitive control of a simple mental image in patients with obsessive-compulsive disorder. Brain Cogn. 2011;76(3):390-399.
10. Hollander E, Schiffman E, Cohen B, et al. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry. 1990;47:27-32.
11. Kuelz AK, Hohagenb F, Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: A critical review. Biol Psychol. 2004;65:185-236.
12. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32:525-549.
13. Cavedini P, Riboldi G, D'Annucci A, et al. Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia. 2002;40:205-211.
14. Fontenelle LF, Lauterbach EC, Telles LL, et al. Catatonia in obsessive-compulsive disorder: Etiopathogenesis, differential diagnosis, and clinical management. Cogn Behav Neurol. 2007;20(1):21-24.
15. Hermesh H, Hoffnung RA, Aizenberg D, et al. Catatonic signs in severe obsessive compulsive disorder. J Clin Psychiatry. 1989;50(8):303-305.
16. Blacker KH. Obsessive-compulsive phenomena and catatonic statesVa continuum. A five-year case study of a chronic catatonic patient. Psychiatry. 1966;29(2):185-194.
17. Maletzky B, McFarland B, Burt A. Refractory obsessive compulsive disorder and ECT. Convuls Ther. 1994;10:34-42.
18. Ogai M, Iyo M, Mori N, et al. A right orbitofrontal region and OCD symptoms: A case report. Acta Psychiatr Scand. 2005;111(1):74-76; discussion 76-7.
19. Busatto GF, Buchpiguel CA, Zamignani DR, et al. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: An exploratory SPECT study. J Am Acad Child Adolesc Psychiatry. 2001;40:347-354.
20. Hollander E, DeCaria C, Saoud J, et al. Neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48: 278-279.